CCO Independent Conference Coverage
2008 Annual Meeting of the European Association for the Study of the Liver*
April 23-27, 2008 | Milan, Italy
*CCO is an independent medical education company that provides state-of-the-art
medical information to healthcare professionals through conference coverage and other educational programs.
Update on Hepatitis B Management
|
Track 1 of 4
|
|
|
|
   |
- Kris V. Kowdley, MD, FACP, FACG, FASGE, AGAF
- Patrick Marcellin, MD
- Norah Terrault, MD, MPH
|
|
|
Focus on Investigational HCV Agents
|
Track 2 of 4
|
|
|
|
   |
- Nezam H. Afdhal, MD, FRCPI
- Ira M. Jacobson, MD
- Stefan Zeuzem, MD
|
|
|
New Advances in Hepatitis C
|
Track 3 of 4
|
|
|
|
   |
- Alfredo Alberti, MD
- Peter Ferenci, MD
- Michael P. Manns, MD
|
|
|
Highlight on Special Hepatic Issues and Populations
|
Track 4 of 4
|
|
|
|
   |
- Robert G. Gish, MD
- Josep M. Llovet, MD
- Paul Martin, MD
|
|
|
Expert Highlights
 |
Michael P. Manns, MD, highlights the clinical implications of trials performed in hepatitis C nonresponders and relapsers as well as results from a late-breaker presentation comparing the 2 available formulations of peginterferon. (9 minutes)
|
 |
Download Audio |
 |
Stefan Zeuzem, MD, highlights data from EASL 2008 on 2 of the most clinically advanced classes of investigational hepatitis C agents—protease inhibitors and nucleoside polymerase inhibitors. (7 minutes)
|
 |
Download Audio |
 |
Maria Buti-Ferret, MD, discusses key efficacy and resistance HBV data presented at the meeting in Milan, including reports in treatment-naive patients and strategies for patients with resistance. (12 minutes)
|
 |
Download Audio |
 |
Robert G. Gish, MD, discusses key presentations on insulin resistance, portal hypertension and cirrhosis, approved and investigational treatments for HCC, liver transplantation, and treatment of autoimmune hepatitis. (10 minutes)
|
 |
Download Audio |
Disclaimer: The materials published on the Clinical Care Options
Web site reflect the views of the reviewers or authors of the
CCO
material, not those of Clinical Care Options, LLC, the CME provider,
or the companies providing educational grants. The materials may
discuss uses and dosages for therapeutic products that have not been
approved by the United States Food and Drug Administration. A qualified
healthcare professional should be consulted before using any therapeutic
product discussed. Readers should verify all information and data before
treating patients or using any therapies described in these materials.
|
Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|